158 related articles for article (PubMed ID: 6785785)
1. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
Fobes JL; Olds ME
Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamine.
Olds ME; Fobes JL; Albert V
Psychopharmacology (Berl); 1981; 73(1):31-3. PubMed ID: 6785786
[TBL] [Abstract][Full Text] [Related]
3. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
[TBL] [Abstract][Full Text] [Related]
4. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
Morgan DN; McLean JH; Kostrzewa RM
Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
[TBL] [Abstract][Full Text] [Related]
5. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
Stockmeier CA; Larsen BR; Blask DE
J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
[TBL] [Abstract][Full Text] [Related]
6. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup.
Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA
Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577
[TBL] [Abstract][Full Text] [Related]
7. Use of 6-hydroxydopamine to deplete brain catecholamines in the rhesus monkey: effects on urinary catecholamine metabolites and behavior.
Kraemer GW; Breese GR; Prange AJ; Moran EC; Lewis JK; Kemnitz JW; Bushnell PJ; Howard JL; McKinney WT
Psychopharmacology (Berl); 1981; 73(1):1-11. PubMed ID: 6785782
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and electrocortical activity in rats after neonatal intraventricular 6-hydroxydropamine administration.
Nyakas C; Van Delft AM
Pharmacol Biochem Behav; 1975; 3(2):271-7. PubMed ID: 1144483
[TBL] [Abstract][Full Text] [Related]
9. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
[TBL] [Abstract][Full Text] [Related]
10. Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat.
Pappas BA; Peters DA; Sobrian AK; Blouin A; Drew B
Pharmacol Biochem Behav; 1975; 3(4):681-5. PubMed ID: 242015
[TBL] [Abstract][Full Text] [Related]
11. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
[TBL] [Abstract][Full Text] [Related]
12. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
Mason ST; Iverson SD
Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
[No Abstract] [Full Text] [Related]
13. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
Heffner TG; Seiden LS
Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
[TBL] [Abstract][Full Text] [Related]
14. Behavior and neurochemical changes following administration of 6-hydroxydopamine into the ventral tegmental area of the midbrain.
Nakamura K; Nakamura K
Jpn J Pharmacol; 1976 Apr; 26(2):269-73. PubMed ID: 945851
[No Abstract] [Full Text] [Related]
15. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
Versteeg DH; van Ree JM; Provoost AP; de Jong W
Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
[No Abstract] [Full Text] [Related]
16. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
Erinoff L; MacPhail RC; Heller A; Seiden LS
Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
[TBL] [Abstract][Full Text] [Related]
17. Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels.
Oke A; Freeman R; Adams RN
Eur J Pharmacol; 1974 Apr; 26(1):125-7. PubMed ID: 4831981
[No Abstract] [Full Text] [Related]
18. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
Concannon JT; Braughler JM; Schechter MD
Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
[TBL] [Abstract][Full Text] [Related]
19. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
Miller FE; Heffner TG; Kotake C; Seiden LS
Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
[TBL] [Abstract][Full Text] [Related]
20. Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups.
Shaywitz BA; Pearson DA
Pharmacol Biochem Behav; 1978 Aug; 9(2):173-9. PubMed ID: 714967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
